UPDATE: Wunderlich Securities Reiterates Buy Rating, Raises PT on DexCom
Posted on January 14, 2013 at 09:17 AM EST
In a report published Monday, Wunderlich Securities reiterated its Buy rating on DexCom (NASDAQ: DXCM ), and raised its price target from $15.00 to $18.00. Wunderlich Securities noted, “We are raising our price target on DexCom (DXCM) to $18 per share from $15, reflecting the strong, initial success of the